| 英文别名 |
ivermectin;22,23-DIHYDROAVERMECTIN B1;22,23-DIHYDROAVERMECTINE;CARDOMEC;EQVALEN;heartgard-30;IVERMECTINE;IVOMEC;hyvermectin;mk-0933;mk933;IVERMECTIN HCL;Ivermectin EP2000;IVERMECTIN EP(CRM STANDARD);IVERMECTIN USP(CRM STANDARD);IvermectineEp2000;IVERMECTINE(PATENT-NOSUPPLY);22,23-Dihydro C-076B1;Ivosint;Ivermectin Solution;IVERMECTIN, EP 7.0;Ivermecti;Mectizan;Uvemec;Vermic;WAKO090-05521;vermectin;MK-933;(4S,5'S,6R,6'R,8R,10E,12S,13S,14E,16E,20R,21R,24S)-6'-[(2S)-Butan-2-yl]-21,24-dihydroxy-12-[(2R,4S,5;Ivermectin B1a;Dihydroavermectin B1a;22,23-Dihydroavermectin B1a;avermectin H2B1a;91Y2202OUW;FT-0601609;71827-03-7;NS00077983;(1S,4S,5'S,6R,6'R,8R,10E,12S,13S,14E,16E,20R,21R,24S)-6'-[(2S)-butan-2-yl]-21,24-dihydroxy-12-[(2R,4S,5S,6S)-5-[(2S,4S,5S,6S)-5-hydroxy-4-methoxy-6-methyloxan-2-yl]oxy-4-methoxy-6-methyloxan-2-yl]oxy-5',11,13,22-tetramethylspiro[3,7,19-trioxatetracyclo[15.6.1.14,8.020,24]pentacosa-10,14,16,22-tetraene-6,2'-oxane]-2-one;70288-86-7;epi-Ivermectin B1a;CHEBI:201533;AB00513813_04;BRD-K85554912-001-06-3;Ivermectin, United States Pharmacopeia (USP) Reference Standard;(2aE,4E,5'S,6S,6'R,7S,8E,11R,13R,15S,17aR,20R,20aR,20bS)-6'-[(2S)-butan-2-yl]-20,20b-dihydroxy-5',6,8,19-tetramethyl-17;Ivermectin (IVM);BRD-K85554912-001-05-5;CCG-220156;DTXCID303181;70161-11-4;DTXSID8023181;(1R,4S,5'S,6R,6'R,8R,10E,12S,13S,14E,16E,20R,21R,24S)-6'-[(2S)-butan-2-yl]-21,24-dihydroxy-12-[(2R,4S,5S,6S)-5-[(2S,4S,5S,6S)-5-hydroxy-4-methoxy-6-methyloxan-2-yl]oxy-4-methoxy-6-methyloxan-2-yl]oxy-5',11,13,22-tetramethylspiro[3,7,19-trioxatetracyclo[15.6.1.14,8.020,24]pentacosa-10,14,16,22-tetraene-6,2'-oxane]-2-one;CAS-71827-03-7;WCA82703;Prestwick3_000156;5-O-demethyl-22,23-dihydroavermectin A1a;Tox21_112034;Ivermectin (MK-0933);HMS2095O14;BSPBio_000292;CHEBI:63941;BRN 4643153;22,23-Dihydroavermectin B(1)a;Avermectin A1a, 22,23-dihydro-5-O-demethyl-;Stromectol;Avermectin A1a, 5-O-demethyl-22,23-dihydro-; Spiro[11,15-methano-2H,13H,17H-furo[4,3,2-pq][2,6]benzodioxacyclooctadecin-13,2'-[2H]pyran], avermectin A1a deriv.; 22,23-Dihydroavermectin B1a; 5-O-Demethyl-22,23-dihydroavermectin A1a; Dihydroavermectin B1a; Ivermectin B1a;BPBio1_000322;NCGC00186639-03;UNII-91Y2202OUW;C48H74O14;H2B1a;Ivermectin Component B1a;AB00513813;Ivermectin, British Pharmacopoeia (BP) Reference Standard;22,23-DIHYDROAVERMECTIN B1A; IVERMECTIN;Ivermectin, European Pharmacopoeia (EP) Reference Standard;AB00513813-03;Ivermectin B1a-d2;BRD-K24652731-001-02-7;BRD-K85554912-001-08-9;AS-14167;Avermectin A1a, 5-O-demethyl-22,23-dihydro-;(2aE,4E,5'S,6S,6'R,7S,8E,11R,13R,15S,17aR,20R,20aR,20bS)-6'-[(2S)-butan-2-yl]-20,20b-dihydroxy-5',6,8,19-tetramethyl-17 -oxo-3',4',5',6,6',10,11,14,15,17,17a,20,20a,20b-tetradecahydro-2H,7H-spiro[11,15-methanofuro[4,3,2-pq][2,6]benzodioxacy clooctadecine-13,2'-pyran]-7-yl 2,6-dideoxy-4-O-(2,6-dideoxy-3-O-methyl-alpha-L-arabino-hexopyranosyl)... |
